Genmab And 3 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) – Genmab (GMAB), Brookfield (BAM), CoStar Group (CSGP) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Genmab (GMAB)

17.9% sales growth and 14.78% return on equity

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC. Its products include daratumumab to treat MM, non-MM blood cancers, and AL amyloidosis; GEN1047; tisotumab vedotin for treating cervical, ovarian, and solid cancers; DuoBody-PD-L1x4-1BB, and DuoBody-CD40x4-1BB for treating solid tumors; Epcoritamab for relapsed/refractory diffuse large B-cell lymphoma and chronic lymphocytic leukemia; and HexaBody-CD38 and GEN3017 for treating hematological malignancies. In addition, the company develops Inclacumab, which is in Phase 3 trial for vaso-occlusive crises; Camidanlumab tesirine to treat hodgkin lymphoma and solid tumors; JNJ-64007957 and JNJ-64407564 to treat MM; PRV-015 for treating celiac disease; Mim8 for treating haemophilia A; and Lu AF82422 for treating multiple system atrophy disease. It operates various active pre-clinical programs. The company has a commercial license and collaboration agreement with Seagen Inc. to co-develop tisotumab vedotin. It also has a collaboration agreement with argenx to discover, develop, and commercialize novel therapeutic antibodies with applications in immunology and oncology; and AbbVie for the development of epcoritamab, as well as collaborations with BioNTech, Janssen, and Novo Nordisk A/S. Genmab A/S was founded in 1999 and is headquartered in Copenhagen, Denmark.

Earnings Per Share

As for profitability, Genmab has a trailing twelve months EPS of $0.96.

PE Ratio

Genmab has a trailing twelve months price to earnings ratio of 30.88. Meaning, the purchaser of the share is investing $30.88 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.78%.

Revenue Growth

Year-on-year quarterly revenue growth declined by 8.9%, now sitting on 16.47B for the twelve trailing months.

2. Brookfield (BAM)

13% sales growth and 20.63% return on equity

Brookfield Asset Management Ltd. is a real estate investment firm specializing in alternative asset management services. Its renewable power and transition business includes the operates in the hydroelectric, wind, solar, distributed generation, and sustainable solution sector. The company's infrastructure business engages in the utilities, transport, midstream, and data infrastructure sectors. In addition, its private equity business offers industrial, infrastructure, and business services sectors; and real estate business, which includes housing, logistics, hospitality, science and innovation, office, and retail sectors. Further, it provides credit business; and insurance solution in the reinsurance, annuities, operating platform, and investment solutions sectors. Brookfield Asset Management Ltd. was incorporated in 2022 and is headquartered in Toronto, Canada.

Earnings Per Share

As for profitability, Brookfield has a trailing twelve months EPS of $1.12.

PE Ratio

Brookfield has a trailing twelve months price to earnings ratio of 36.21. Meaning, the purchaser of the share is investing $36.21 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.63%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Brookfield’s EBITDA is 100.39.

Revenue Growth

Year-on-year quarterly revenue growth grew by 1.2%, now sitting on 4.06B for the twelve trailing months.

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Feb 28, 2024, the estimated forward annual dividend rate is 1.52 and the estimated forward annual dividend yield is 3.61%.

Previous days news about Brookfield(BAM)

  • Brookfield infrastructure announces results of conversion of its series 1 senior preferred shares. According to GlobeNewsWire on Tuesday, 19 March, "Brookfield Infrastructure is the flagship listed infrastructure company of Brookfield Asset Management, a global alternative asset manager with over US$900 billion of assets under management. ", "BROOKFIELD, NEWS, March 19, 2024 (GLOBE NEWSWIRE) — Brookfield Infrastructure (NYSE: BIP; TSX: BIP.UN) today announced that after having taken into account all conversion notices received by the March 18, 2024 deadline for the conversion of BIP Investment Corporation’s ("BIPIC") Senior Preferred Shares, Series 1 ("Series 1 Shares") (TSX: BIK.PR."

3. CoStar Group (CSGP)

12% sales growth and 5.27% return on equity

CoStar Group, Inc. provides information, analytics, and online marketplace services to the commercial real estate, hospitality, residential, and related professionals industries in the United States, Canada, Europe, the Asia Pacific, and Latin America. The company offers CoStar Property that provides inventory of office, industrial, retail, multifamily, hospitality, and student housing properties and land; CoStar Sales, a robust database of comparable commercial real estate sales transactions; CoStar Market Analytics to view and report on aggregated market and submarket trends; and CoStar Tenant, an online business-to-business prospecting and analytical tool that provides tenant information. It also provides Leasing, a tool to capture, manage, and maintain lease data; CoStar Lease Analysis; Public Record, a searchable database of commercially zoned parcels; CoStar Real Estate Manager, a real estate lease administration, portfolio management, and lease accounting compliance software solution; and CoStar Risk Analytics and CoStar Investment. In addition, it offers apartment marketing sites, such as ApartmentFinder.com, ForRent.com, ApartmentHomeLiving.com, WestsideRentals.com, AFTER55.com, CorporateHousing.com, ForRentUniversity.com, Apartamentos.com, and Off Campus Partners; LoopNet Premium Lister; LoopNet Diamond, Platinum, and Gold Ads; LandsofAmerica.com, LandAndFarm.com, and LandWatch.com for rural land for-sale; BizBuySell.com, BizQuest.com, and FindaFranchise.com for operating businesses and franchises for-sale; Ten-X, an online auction platform for commercial real estate; and HomeSnap, an online and mobile software platform, as well as Homes.com, a homes for sale listings site. The company was founded in 1987 and is headquartered in Washington, the District of Columbia.

Earnings Per Share

As for profitability, CoStar Group has a trailing twelve months EPS of $0.92.

PE Ratio

CoStar Group has a trailing twelve months price to earnings ratio of 102.28. Meaning, the purchaser of the share is investing $102.28 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.27%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is a negative 79.3% and a negative 67.7%, respectively.

4. ONE Gas (OGS)

6% sales growth and 8.64% return on equity

ONE Gas, Inc., together with its subsidiaries, operates as a regulated natural gas distribution company in the United States. The company provides natural gas distribution services to approximately 2.3 million customers in Oklahoma, Kansas, and Texas. It serves residential, commercial, and transportation customers. The company was founded in 1906 and is headquartered in Tulsa, Oklahoma.

Earnings Per Share

As for profitability, ONE Gas has a trailing twelve months EPS of $4.14.

PE Ratio

ONE Gas has a trailing twelve months price to earnings ratio of 15.03. Meaning, the purchaser of the share is investing $15.03 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 8.64%.

Volume

Today’s last reported volume for ONE Gas is 403339 which is 12.8% below its average volume of 462581.

Leave a Reply

Your email address will not be published. Required fields are marked *